Among the emerging circulating biomarkers, Protein Induced by Vitamin K Absence (PIVKA II), also known as Des-γ-Carboxy prothrombin (DCP), an established tumor marker for hepatocellular carcinoma (HCC), is the most promising [8,9,10]. This evidence concerns the gene ACE and hepatocellular carcinoma.